MBX Microbix Biosystems Inc.
Financings ·
MBX Biosciences filed an S-1 on September 22, 2025 for 10,000,000 shares. The deal priced on September 24 at $18.00 for 11,108,055 shares and closed on September 26 with net proceeds of about $187.5 million.
We have not published a story on Microbix Biosystems yet. When there is news, it will appear here.
| Line | FY2025 | FY2024 |
|---|---|---|
| Research and development | $79.2 million | $57.4 million |
| Net income (loss) | -$87.0 million | -$61.9 million |
| Cash from operations | -$79.9 million | -$54.7 million |
| Cash and equivalents | $75.3 million | $49.4 million |
| Short-term investments | $298.4 million | $212.8 million |
Our latest story on this, dated Sep 22, 2025: "MBX Biosciences files for 10,000,000-share offering, later sells 11,108,055 at $18.00". The story links the filing or release it is based on. Read the story.
Microbix Biosystems Inc. trades under the ticker MBX on TSX.
Microbix Biosystems Inc. is listed on TSX. Our directory also records these other listings: NEO:MBX; OTC:MBXBF.
Our directory records Microbix Biosystems Inc. under Canada.
Our directory classifies Microbix Biosystems Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.
The ISIN recorded for Microbix Biosystems Inc. is CA59501P1045.
aibio.space lists Microbix Biosystems Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Microbix Biosystems Inc. reported a net loss of $87.0 million for the fiscal year ended Dec 31, 2025, and used $79.9 million of cash in operations, per its annual report to the SEC.
$79.2 million in the fiscal year ended Dec 31, 2025, per its annual report.
$418.6 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
Our latest story on Microbix Biosystems, dated Sep 22, 2025: "MBX Biosciences files for 10,000,000-share offering, later sells 11,108,055 at $18.00". MBX Biosciences filed an S-1 on September 22, 2025 for 10,000,000 shares. The deal priced on September 24 at $18.00 for 11,108,055 shares and closed on September 26 with net proceeds of about $187.5 million. Source.
Companies in our directory listed in the same country and business area as Microbix Biosystems: Medicus Pharma, Sernova Biotherapeutics, Avicanna, ZENITH CAPITAL CORPORATION, Vaxil Bio, ME Therapeutics Holdings.
Press Follow on this page to add Microbix Biosystems to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Microbix Biosystems so far, in Financings.
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio